Nov 5 (Reuters) - Demant A/S DEMANT.CO:
SAID ON TUESDAY Q3 REVENUE DKK 5,454 MLN VS DKK 5,401 MLN YR AGO
Q3 ORGANIC GROWTH OF 3% DRIVEN BY SOLID PERFORMANCE IN HEARING CARE
SAYS Q3 EBIT WAS IN LOWER END OF EXPECTATIONS, PRIMARILY DUE TO LOWER-THAN-EXPECTED GROSS MARGIN, NEGATIVE IMPACT FROM FOREX
OUTLOOK FOR 2025: ORGANIC GROWTH OF 1-3%, EBIT OF DKK 3,900-4,300 MLN, BOTH LIKELY IN LOWER END
HEARING CARE PERFORMED VERY WELL, AND HEARING AIDS GAINED UNIT MARKET SHARE, BUT GROUP'S PERFORMANCE WAS IMPACTED BY SEQUENTIAL SLOWDOWN IN US COMMERCIAL MARKET
Source text for Workspace: [Link]
Further company coverage: DEMANT.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))